07.06.2013
- U.S. health advisers voted on Thursday to recommend relaxing market restrictions on GlaxoSmithKline's diabetes drug Avandia, the former blockbuster at the center of one of the...
01.05.2013
- Denmark's Novo Nordisk could see the U.S. launch of its biggest drug hope, a new long-acting insulin, delayed until 2018 while it conducts more tests to satisfy regulators, it said...
26.02.2013
- The U.S. Food and Drug Administration said on Tuesday it has stopped all pediatric clinical trials of Amgen's Sensipar after the death of a 14-year-old patient taking part in a...
25.02.2013
- U.S.-based Affymax and Japan's Takeda Pharmaceutical said they are voluntarily recalling all lots of anemia treatment Omontys (peginesatide) in the United States due to reports of...
